期刊文献+

医用组织黏合剂黏合兔眼巩膜穿通伤口与传统缝合的对比实验研究 被引量:2

Comparative study on tissue adhesive and suturing for sclerotic penetrating wound in rabbits
下载PDF
导出
摘要 目的探讨a-氰基丙烯酸正辛酯为主体的医用化学组织黏合剂密闭兔眼巩膜全层裂伤的可能性。方法45只成年兔建立经巩膜穿通伤模型,右眼用医用胶黏合,左眼缝线缝合,术后3、7、14、30、90天观察医用胶的降解,对比观察伤口组织病理学愈合情况。结果医用胶能够迅速密闭巩膜伤口。术后各观察时间点,眼前、后节均未观察到炎症反应。电镜和光镜观察组织伤口均愈合。随巩膜伤口愈合,抗球内压力逐渐增加。医用化学组织黏合剂术后3个月分解吸收。结论医用化学组织黏合剂可有效密闭巩膜穿通伤。 Objective To investigate the feasibility of adhesion of chemical tissue adhesive ( 2-Octyl Cyanoacrylate) for sclerotic penetrating wound. Methods Forty-five Japan rabbits were randomly divided into five groups,each group had nine rabbits. Right eyes were cyanoacrylate adhesive group,left eyes were suture group. On days 3,7,14,30 and 90 after surgery,the conditions of conjunctiva and anterior chamber were observed by Slit-lamp biomicroscopy after surgery ; the condition of sclerotic wound healing and cyanoacrylate adhesive degradation were ob- served;the tensile strength of eyeball was measured;the tissue of corneal wounds were observed by light microscope and transmission electron microscope examination. Results The medical adhesive quickly occluded the sclerotic penetrating wounds during operation. After surgery inflammation was not found in the eyes in the adhesive groups. Light microscope observations showed the wounds cicatrized. The tensile strengths of sclerotic wounds were increasing with time. Finally, the medical adhesive was degraded and absorbed. Transmission electron microscope observations showed that shape and structure of sclera collagen fiber and fibroblasts were similar in both groups. Conclusion The initial study demonstrates the adhesion for sclerotic penetrating wound with CA is available.
出处 《创伤外科杂志》 2008年第5期443-446,共4页 Journal of Traumatic Surgery
基金 全军医学科研"十一五"计划资助(06G072)
关键词 巩膜 穿透伤 组织黏合剂 a-氰基丙烯酸正辛酯 缝合 sclerotic penetrating wound tissue adhesion cyanoacrylate suturing rabbits
  • 相关文献

参考文献7

  • 1陈家祺,刘文,刘祖国,陈龙山,黄挺,郑湖玲.血管内皮生长因子及其受体在病变角膜的表达和临床意义的探讨[J].眼科学报,2002,18(4):203-207. 被引量:10
  • 2Ritterband DC, Meskin SW, Shapiro DE, et al. Laboratory model of tissue adhesive (2-octyl cyanoacrylate) in sealing clear corneal cataract wounds[ J ]. Am J Ophthalmol,2005, 140(6) :1039 - 1043.
  • 3Leung GY, Peponis V, Varneu ED, et al. Preliminary in vitro evaluation of 2-octyl cyanoacrylate ( dermabond ) to seal corneal Incisions [ J ]. Cornea, 2005,24 ( 8 ) : 998 - 999.
  • 4Masetti L, Bellei E, Dalla F, et al. Use of glubran 2 in ophthalmic surgery: a preliminary study [ J ]. Vet Res Commun ,2007,31 ( 1 ) :305 - 307.
  • 5Ferraz LC,Schellini SA,Wludarski SL,et al. 2-octyl-cyanoacrylate in rabbit anophthalmic cavity reconstruction [ J ]. Arq Bras Oftalmol,2007,70 (2) : 221 - 224.
  • 6夏穗生,田霞,卢永顺.新一代喷涂型福爱乐医用胶(基础研究)[J].临床外科杂志,2003,11(2):120-121. 被引量:40
  • 7Chen WL, Lin CT. Comparison of the bacteriostatic effects, corneal cytotoxicity,and the ability to seal corneal incisions among three different tissue adhesives [ J ]. Cornea, 2007, 26(10) :1228 - 1234.

二级参考文献14

  • 1[1]Casey R, Li WW. Factors controlling ocular angiogenesis.Am J Ophthalmol 1997; 124:521 - 529.
  • 2[2]Philipp W, Speicher L, Humpet C. Expression of vascular endothelial growth factor and its receptors in inflamed and vascularized human corneas. Invest Ophthalmol Vis Sci 2000; 41: 2514 - 2522.
  • 3[3]Cursiefen C, Rummelt C, Kuchle M. Immunohistochemical localization of vascular endothelial growth factor,transforming growth factor α, and transforming growth factor β1 in human corneas with neovascularization. Cornea 2000; 19:526 - 533.
  • 4[4]Miller JW. Vascular endothelial factor and ocular neovascularization. Am J Pathology 1997; 151:13 -23.
  • 5[5]Aiello LP. Vascular endothelial growth factor. Invest Ophthalmol Vis Sci 1997; 38:1647 - 1652.
  • 6[6]Van Setten GB. Vascular endothelial growth factor(VEGR)in normal human corneal epithelium: detection and physiological importance. Acta Ophthalmol Scand 1997;75:649 - 665.
  • 7[7]Loughnan MS, Chatzistefanou K, Gonzalez EM, et al.Experimental corneal neovascularisation using sucralfate and basic fibroblast growth factor. Aust N Z J Ophthalmol 1996; 24:289 - 295.
  • 8[8]Edelman JL, Castro MR, Wen Y. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea. Invest Ophthalmol Vis Sci 1999; 40:1112 - 1123.
  • 9[9]Amano S, Rohan R, Kuroki M, et al. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization. Invest Ophthalmol Vis Sci 1998; 39: 18- 22.
  • 10[10]Friedlander M, Brooks PC, Shaffer RW, et al. Definition of two angiogenic pathways by distinct αv integrins. Science 1995; 270:1500 - 1502.

共引文献48

同被引文献24

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部